[Progress in cardiovascular pharmacology].
作者信息
Zhu J R
出版信息
Zhonghua Xin Xue Guan Bing Za Zhi. 1993 Dec;21(6):358-60.
PMID:7913889
Abstract
摘要
相似文献
1
[Progress in cardiovascular pharmacology].[心血管药理学进展]
Zhonghua Xin Xue Guan Bing Za Zhi. 1993 Dec;21(6):358-60.
2
[Drugs used in cardiovascular diseases and cytokines].[用于心血管疾病的药物与细胞因子]
Wiad Lek. 2006;59(3-4):232-7.
3
Cardiovascular drug therapy in the elderly.老年人的心血管药物治疗
Cardiol Rev. 2007 Jul-Aug;15(4):195-215. doi: 10.1097/CRD.0b013e3180301b69.
4
[Treatment of heart failure and preserved systolic function].[射血分数保留的心力衰竭的治疗]
Lakartidningen. 2007;104(34):2348-50.
5
Cardiac medication in the perioperative period.围手术期的心脏药物治疗
Acta Anaesthesiol Scand Suppl. 1997;111:22-8.
6
Calcium-channel antagonists in cardiovascular disease.
Br J Hosp Med. 1997;57(11):552-6.
7
Pharmacological treatment for myocardial infarction Part 2: Implications of clinical trials of other adjunctive therapies.
Indian Heart J. 1995 Mar-Apr;47(2):95-105.
8
Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases.慢性心血管疾病药物治疗中的女性特异性方面。
Eur Heart J. 2005 Aug;26(16):1585-95. doi: 10.1093/eurheartj/ehi397. Epub 2005 Jul 4.
9
Cardiovascular pharmacotherapy in patients with Marfan syndrome.马凡综合征患者的心血管药物治疗
Am J Cardiovasc Drugs. 2007;7(2):117-26. doi: 10.2165/00129784-200707020-00003.
10
Merck Serono targets convenient, affordable medicines for patients at risk.默克雪兰诺致力于为有患病风险的患者提供便捷且价格合理的药物。
Cardiovasc J Afr. 2009 Jan-Feb;20(1):77.
Zotero 插件